“…ILC1 have a beneficial role during the early immune response in mice to Mouse Cytomegalovirus (MCMV) in the liver, to Toxoplasma gondii in the brain, and to epithelial infection with Cryptosporidium parvum, but can also be pathogenic in association with colitis in mouse models, and during IBD in humans [1, 19,28,29,47,48]. The detrimental effect of ILC1 appears to be mediated by the production of IFNγ and TNFα, both of which induce apoptosis of epithelial cells in vitro, which is likely to contribute to disruption of the intestinal barrier in vivo and to microbiota-driven inflammation [9,[49][50][51].…”